Hemostats Market Size, Share Report, Analysis, Trends, Growth 2032

Hemostats Market

Hemostats Market Analysis By Product Type (Gelatin-based Hemostats, Thrombin-based, Collagen-based Hemostats, Oxidized Regenerated Cellulose Based Hemostats, and Combination Hemostats), and By Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2024-2032

Category: Medical Device Report Format : PDF Pages: 200 Report Code: ZMR-1555 Published Date: Jul-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 2.72 Billion USD 4.33 Billion 5.40% 2023

Hemostats Market

Table Of Content

  • Chapter 1.Preface
    • 1.1.Report Description
    • 1.2.Report Scope
  • Chapter 2.Research Methodology
    • 2.1.Research Methodology
    • 2.2.Secondary Research
    • 2.3.Primary Research
    • 2.4.Models
      • 2.4.1.Company Share Analysis Model
      • 2.4.2.Revenue Based Modeling
    • 2.5.Research Limitations
  • Chapter 3.Executive Summary
    • 3.1.Global Hemostats Market, 2016 – 2026 (USD Million)
    • 3.2.Global Hemostats Market: Snapshot
  • Chapter 4.Hemostats Market – Industry Analysis
    • 4.1.Introduction
    • 4.2.Market Drivers
      • 4.2.1.Driving Factor 1 Analysis
      • 4.2.2.Driving Factor 2 Analysis:
    • 4.3.Market Restraints
      • 4.3.1.Restraining Factor Analysis
    • 4.4.Market Opportunities
      • 4.4.1.Market Opportunity & Use-case Anaysis
      • 4.4.2.Use – Cases for Hemostats
    • 4.5.Porter’s Five Forces Analysis
    • 4.6.COVID 19 Impact Analysis
      • 4.6.1.1.Impact on Product Development and Technology Adoption
      • 4.6.1.2.Gap Analysis
  • Chapter 5.Investment Proposition Analysis
    • 5.1.Global Hemostats Market Attractiveness, By Product Type
    • 5.2.Global Hemostats Market Attractiveness, By Region
  • Chapter 6.Competitive Landscape
    • 6.1.Strategic Developments
  • Chapter 7.Hemostats Market – Product Type Segment Analysis
    • 7.1.Global Hemostats Market Overview: by Product Type
      • 7.1.1.Global Hemostats Market Revenue Share, by Product Type, 2019 & 2026
    • 7.2.Global Hemostats Market Analysis/Overview – By Product Type
      • 7.2.1.Gelatin-based Hemostats – Overview/Analysis
      • 7.2.2.Thrombin-based Hemostats – Overview/Analysis
      • 7.2.3.Cullagen-based Hemostats – Overview/Analysis
      • 7.2.4.Oxidized Regenerated Cellulose Based Hemostats – Overview/Analysis
      • 7.2.5.Combination Hemostats – Overview/Analysis
    • 7.3.Gelatin-based Hemostats
      • 7.3.1.Global Hemostats Market for Gelatin-based Hemostats, Revenue (USD Million) 2016 - 2026
    • 7.4.Thrombin-based Hemostats
      • 7.4.1.Global Hemostats Market for Thrombin-based Hemostats, Revenue (USD Million) 2016 - 2026
    • 7.5.Cullagen-based Hemostats
      • 7.5.1.Global Hemostats Market for Cullagen-based Hemostats, Revenue (USD Million) 2016 - 2026
    • 7.6.Oxidized Regenerated Cellulose Based Hemostats
      • 7.6.1.Global Hemostats Market for Oxidized Regenerated Cellulose Based Hemostats, Revenue (USD Million) 2016 - 2026
    • 7.7.Combination Hemostats
      • 7.7.1.Global Hemostats Market for Combination Hemostats, Revenue (USD Million) 2016 - 2026
  • Chapter 8.Hemostats Market – Regional Analysis
    • 8.1.Global Hemostats Market: Regional Overview
      • 8.1.1.Global Hemostats Market Revenue Share, by Region, 2019 & 2026
      • 8.1.2.Global Hemostats Market Revenue, by Region, 2016 – 2026 (USD Million)
    • 8.2.North America
      • 8.2.1.North America Hemostats Market Revenue, 2016 - 2026 (USD Million)
      • 8.2.2.North America Hemostats Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 8.2.3.North America Hemostats Market Revenue, by Product Type, 2016 – 2026
      • 8.2.4. U.S.
      • 8.2.5.Canada
      • 8.2.6.Mexico
    • 8.3.Europe
      • 8.3.1.Europe Hemostats Market Revenue, 2016 - 2026 (USD Million)
      • 8.3.2.Europe Hemostats Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 8.3.3.Europe Hemostats Market Revenue, by Product Type, 2016 – 2026
      • 8.3.4.Germany
      • 8.3.5.France
      • 8.3.6. U.K.
      • 8.3.7.Italy
      • 8.3.8.Spain
      • 8.3.9.Rest of Europe
    • 8.4.Asia Pacific
      • 8.4.1.Asia Pacific Hemostats Market Revenue, 2016 - 2026 (USD Million)
      • 8.4.2.Asia Pacific Hemostats Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 8.4.3.Asia Pacific Hemostats Market Revenue, by Product Type, 2016 – 2026
      • 8.4.4.China
      • 8.4.5.Japan
      • 8.4.6.India
      • 8.4.7.South Korea
      • 8.4.8.South-East Asia
      • 8.4.9.Rest of Asia Pacific
    • 8.5.Latin America
      • 8.5.1.Latin America Hemostats Market Revenue, 2016 - 2026 (USD Million)
      • 8.5.2.Latin America Hemostats Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 8.5.3.Latin America Hemostats Market Revenue, by Product Type, 2016 – 2026
      • 8.5.4.Brazil
      • 8.5.5.Rest of Latin America
    • 8.6.The Middle-East and Africa
      • 8.6.1.The Middle-East and Africa Hemostats Market Revenue, 2016 - 2026 (USD Million)
      • 8.6.2.The Middle-East and Africa Hemostats Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 8.6.3.The Middle-East and Africa Hemostats Market Revenue, by Product Type, 2016 – 2026
      • 8.6.4.GCC Countries
      • 8.6.5.South Africa
      • 8.6.6.Rest of Middle-East Africa
  • Chapter 9.Company Profiles
    • 9.1.Anika Therapeutics Inc.
    • 9.2. C.R. Bard
    • 9.3.B. Braun Melsungen
    • 9.4.Pfizer
    • 9.5.3-D Matrix Ltd.
    • 9.6.Medtrade Products Ltd.
    • 9.7.Stryker
    • 9.8.Baxter
    • 9.9.Integra Lifesciences Corporation
    • 9.1.Resorba Medical GmbH.
    • 9.11.Vascular Sulutions Inc.
    • 9.12.Gamma Therapeutics Inc.
    • 9.13.Arch Therapeutics Inc.
    • 9.14.CSL Behring
    • 9.15.Equimedical B.V.
    • 9.16.Biom’Up SAS
    • 9.17.Medline Industries Inc.
    • 9.18.Hemostasis LLC
    • 9.19.CryoLife Inc.
    • 9.2.Mallinckrodt Plc.
    • 9.21.Hemostasis LLC
    • 9.22.Hemotec Medical GmbH.

Table Of Figures

List of Figures  

FIG. 1 Research Methodology
FIG. 2 Research Methodology – Basic Overview
FIG. 3 Research Methodology – Detailed View
FIG. 4 Global Hemostats Market Revenue, 2016 - 2026 (USD Million)
FIG. 5 Porter’s Five Forces Analysis for Global Hemostats Market
FIG. 6 Global Hemostats Market Attractiveness, By Product Type
FIG. 7 Global Hemostats Market Attractiveness, By Region
FIG. 8 Global Hemostats Market Revenue Share, by Product Type, 2019 & 2026
FIG. 9 Global Hemostats Market for Gelatin-based Hemostats, Revenue (USD Million) 2016 - 2026
FIG. 10 Global Hemostats Market for Thrombin-based Hemostats, Revenue (USD Million) 2016 - 2026
FIG. 11 Global Hemostats Market for Collagen-based Hemostats, Revenue (USD Million) 2016 - 2026
FIG. 12 Global Hemostats Market for Oxidized Regenerated Cellulose Based Hemostats, Revenue (USD Million) 2016 - 2026
FIG. 13 Global Hemostats Market for Combination Hemostats, Revenue (USD Million) 2016 - 2026
FIG. 14 Global Hemostats Market Revenue Share, by Region, 2019 & 2026
FIG. 15 North America Hemostats Market Revenue, 2016 - 2026 (USD Million)
FIG. 16 Europe Hemostats Market Revenue, 2016 - 2026 (USD Million)
FIG. 17 Asia Pacific Hemostats Market Revenue, 2016 - 2026 (USD Million)
FIG. 18 Latin America Hemostats Market Revenue, 2016 - 2026 (USD Million)
FIG. 19 The Middle-East and Africa Hemostats Market Revenue, 2016 - 2026 (USD Million)
 


Table Of Tables

List of Tables 

TABLE 1 Global Hemostats Market: Snapshot
TABLE 2 Drivers of the Hemostats Market: Impact Analysis
TABLE 3 Restraints for the Hemostats Market: Impact Analysis
TABLE 4 Global Hemostats Market Revenue, by Region, 2016 – 2026 (USD Million)
TABLE 5 North America Hemostats Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 6 North America Hemostats Market Revenue, by Product Type, 2016 – 2026 (USD Million)
TABLE 7 Europe Hemostats Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 8 Europe Hemostats Market Revenue, by Product Type, 2016 – 2026 (USD Million)
TABLE 9 Asia Pacific Hemostats Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 10 Asia Pacific Hemostats Market Revenue, by Product Type, 2016 – 2026 (USD Million)
TABLE 11 Latin America Hemostats Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 12 Latin America Hemostats Market Revenue, by Product Type, 2016 – 2026 (USD Million)
TABLE 13 The Middle-East and Africa Hemostats Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 14 The Middle-East and Africa Hemostats Market Revenue, by Product Type, 2016 – 2026 (USD Million)
 

Methodology

FrequentlyAsked Questions

Hemostats are medical agents or devices used to stop bleeding during surgical procedures. They help promote blood clotting and wound control.
The global hemostats market is expected to be driven by the rising surgical procedures, trauma care demand, and increasing use of advanced wound management products.
According to study, the global hemostats market size was worth around USD 2.72 Billion in 2023 and is predicted to grow to around USD 4.33 Billion By 2032.
The global hemostats market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 5.40% during the forecast period from 2024-2032.
The global hemostats industry is projected to be challenged by Major challenges include stringent regulatory approvals, compatibility with different surgical procedures, and cost pressures. Risk of adverse reactions and shelf-life stability are also concerns.
The Opportunities include growth in surgical procedures, trauma care demand, and advanced bioresorbable hemostatic agents. Minimally invasive surgeries and faster wound control drive innovation will offer significant growth opportunities in the hemostats market.
Bio-absorbable and rapid-acting formulations; minimally invasive surgical applications; advanced wound care innovations are the emerging trends and innovations impacting the hemostats market.
The global hemostats market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global hemostats market are; Anika Therapeutics, Inc., C.R. Bard, B. Braun Melsungen, Pfizer, 3-D Matrix, Ltd., Medtrade Products Ltd., Stryker, Baxter, Integra Lifesciences Corporation, Resorba Medical GmbH., and Vascular Solutions, Inc. Other influencing market players in the market are Gamma Therapeutics, Inc., Arch Therapeutics Inc., CSL Behring, Equimedical, B.V., Biom’Up SAS, Medline Industries, Inc., Hemostasis, LLC, CryoLife, Inc., Mallinckrodt Plc., Hemostasis, LLC, and Hemotec Medical GmbH. and others.
The report explores crucial aspects of the hemostats market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed